Are dose-finding studies still necessary when targeted therapy is associated with chemotherapy?
Gelibter, Alain J
Are dose-finding studies still necessary when targeted therapy is associated with chemotherapy? [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Oct 2006 - 4668-9; author reply 4669 p. digital
Publication Type: Comment; Letter
1527-7755
10.1200/JCO.2006.08.3576 doi
Antibiotics, Antineoplastic--pharmacology
Antineoplastic Agents--adverse effects
Capecitabine
Clinical Trials as Topic--methods
Cohort Studies
Data Interpretation, Statistical
Deoxycytidine--analogs & derivatives
Erlotinib Hydrochloride
Fluorouracil--analogs & derivatives
Gastrointestinal Tract--drug effects
Humans
Middle Aged
Neoplasms--drug therapy
Protein Kinase Inhibitors--pharmacology
Quinazolines--pharmacology
Research Design
Are dose-finding studies still necessary when targeted therapy is associated with chemotherapy? [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Oct 2006 - 4668-9; author reply 4669 p. digital
Publication Type: Comment; Letter
1527-7755
10.1200/JCO.2006.08.3576 doi
Antibiotics, Antineoplastic--pharmacology
Antineoplastic Agents--adverse effects
Capecitabine
Clinical Trials as Topic--methods
Cohort Studies
Data Interpretation, Statistical
Deoxycytidine--analogs & derivatives
Erlotinib Hydrochloride
Fluorouracil--analogs & derivatives
Gastrointestinal Tract--drug effects
Humans
Middle Aged
Neoplasms--drug therapy
Protein Kinase Inhibitors--pharmacology
Quinazolines--pharmacology
Research Design